Braizon Therapeutics, Inc.
Company Details
Status: Private
Employees: 1-10
Location:
254,entrepreneur lab.,southern research building., the university of tokyo 7-3-1, hongo, bunkyo-ku, tokyo, japan, japan
Type:
sample
Technology:
About: Braizon Therapeutics, Inc. is working to solve the blood brain barrier problem for oligonucleotide therapeutics, removing the need for spinal cord injections to treat neurological disorders.
Our Brain Access platform utilizes novel IP combining polymer nanoparticles with proven targeting methods for targeting therapies to the brain to create IV formulations for our partners. This platform is under development for expansion into small molecule, peptide, and antibody drug delivery into the brain.
HQ'd in Tokyo, Braizon has US operations in Cambridge, MA. enabling our experienced team to offer partnering worldwide for biotech and Pharma with a strategic focus on neurology.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Braizon Therapeutics, Inc. | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.